English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/214477
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Physicochemical and microbiological stability of two new oral liquid formulations of clonidine hydrochloride for pediatric patients

AuthorsMerino-Bohórquez, V.; Delgado-Valverde, Mercedes; García-Palomo, M.; Dávila-Pousa, M. C.; Cañete, C.; Villaronga, M.; Rodríguez-Marrodán, B.; López-Rojas, Rafael; Cameán-Fernández, M.
KeywordsClonidine
Compounding
Stability
HPLC
Microbiology
Issue Date2019
PublisherTaylor & Francis
CitationPharmaceutical Development and Technology 24(4): 465-478 (2019)
AbstractPediatric patients present changing physiological features. Because of the lack of land suitable for commercial management, pediatric specialties very often need to prepare extemporaneous formulations to improve the dosage and administration of drugs for children. Oral liquid formulations are the most suitable for pediatric patients. Clonidine is widely used in the pediatric population for opioid withdrawal, hypertensive crisis, attention deficit disorders and hyperactivity syndrome, and as an analgesic in neuropathic cancer pain. The objective was to study the physicochemical and microbiological stability and determine the shelf life of an oral solution containing 20 µg/mL clonidine hydrochloride in different storage conditions (5 ± 3 °C, 25 ± 3 °C, and 40 ± 2 °C). Using raw material with excipients safe for all pediatric age groups, two oral liquid formulations of clonidine hydrochloride were designed (with and without preservatives). Solutions stored at 5 ± 3 °C (with and without preservatives) were physically and microbiologically stable for at least 90 days in closed containers and for 42 days after opening. Two oral solutions of clonidine hydrochloride 20 µg/mL were developed for pediatric use from raw materials that are readily available and easy to process, containing safe excipients that are stable over a long period of time.
DescriptionThe Pharmaceutical Technology Working Group and Pediatric Pharmacy Working Group of the Spanish Society of Hospital Pharmacy (SEFH).
Publisher version (URL)http://dx.doi.org/10.1080/10837450.2018.1514520
URIhttp://hdl.handle.net/10261/214477
DOIhttp://dx.doi.org/10.1080/10837450.2018.1514520
Identifiersdoi: 10.1080/10837450.2018.1514520
e-issn: 1097-9867
issn: 1083-7450
Appears in Collections:(IBIS) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.